Patent details

EP4106757 Title: METHODS INVOLVING NEUTROPHIL ELASTASE INHIBITOR ALVELESTAT FOR TREATING RESPIRATORY DISEASE MEDIATED BY ALPHA-1 ANTITRYPSIN DEFICIENCY

Basic Information

Publication number:
EP4106757
PCT Application Number:
GB2021050653
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP217143452
PCT Publication Number:
WO2021209739
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS INVOLVING NEUTROPHIL ELASTASE INHIBITOR ALVELESTAT FOR TREATING RESPIRATORY DISEASE MEDIATED BY ALPHA-1 ANTITRYPSIN DEFICIENCY
French Title of Invention:
PROCÉDÉS IMPLIQUANT L'ALVÉLESTAT INHIBITEUR DE L'ÉLASTASE NEUTROPHILE POUR LE TRAITEMENT D'UNE MALADIE RESPIRATOIRE INDUITE PAR UNE DÉFICIENCE EN ALPHA-1 ANTITRYPSINE
German Title of Invention:
METHODEN BEINHALTEND NEUTROPHILE ELASTASE INHIBITOR ALVELESTAT ZUR BEHANDLUNG VON ATEMWEGSERKRANKUNG AUFGRUND VON ALPHA-1 ANTITRYPSIN MANGEL
SPC Number:

Dates

Filing date:
16/03/2021
Grant date:
23/08/2023
EP Publication Date:
28/12/2022
PCT Publication Date:
21/10/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/08/2023
EP B1 Publication Date:
23/08/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
16/03/2041
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/08/2023
 
 

Name:
Mereo Biopharma 4 Limited
Address:
1 Cavendish Place, London Greater London W1G 0QF, United Kingdom (GB)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
24/08/2023
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
PARKIN, Jacqueline
Address:
United Kingdom (GB)

Priority

1

Priority Number:
202005520
Priority Date:
16/04/2020
Priority Country:
United Kingdom (GB)

2

Priority Number:
202005519
Priority Date:
16/04/2020
Priority Country:
United Kingdom (GB)

3

Priority Number:
202062706195 P
Priority Date:
04/08/2020
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/444; A61K 45/06; A61P 11/00; A61P 29/00;

Publication

European Patent Bulletin

1

Issue number:
202334
Publication date:
23/08/2023
Description:
Grant (B1)

2

Issue number:
202426
Publication date:
26/06/2024
Description:
Opposition procedure started

3

Issue number:
202335
Publication date:
30/08/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
6
Annual Fee Amount:
66 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/02/2025
Last Annual Fee Paid Number:
5
Last Annual Fee Paid Amount:
52 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
24/08/2023 Power Of Attorney 1
25/08/2023 Outgoing Correspondence 1